Table 4 Factors associated with the occurrence of 4-year major adverse events
| Â | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | |
Age | 1.05 (1.02–1.08) | 0.002 | 1.05 (1.02–1.08) | 0.001 |
Female sex | 1.15 (0.63–2.13) | 0.646 | 1.06 (0.57–1.95) | 0.865 |
BMI | 0.95 (0.88–1.03) | 0.192 | NA | NA |
Smoking | 1.36 (0.85–2.20) | 0.204 | NA | NA |
Diabetes | 1.55 (1.02–2.38) | 0.042 | 1.62 (1.06–2.48) | 0.026 |
Insulin use | 1.71 (0.86–3.39) | 0.129 | NA | NA |
Hypertension | 0.70 (0.44–1.10) | 0.123 | NA | NA |
Dyslipidemia | 0.81 (0.52–1.27) | 0.356 | NA | NA |
CAD | 1.36 (0.83–2.22) | 0.225 | NA | NA |
Subclinical CAD | 0.33 (0.05–2.34) | 0.265 | NA | NA |
CKD | 1.60 (0.97–2.65) | 0.065 | 1.27 (0.76–2.15) | 0.362 |
PAOD | 0.88 (0.36–2.17) | 0.783 | 0.77 (0.31–1.90) | 0.565 |
Degree of stenosis | 1.01 (0.99–1.03) | 0.379 | NA | NA |
SCSO | 1.26 (0.67–2.38) | 0.472 | NA | NA |
Symptomatic stenosis | 0.83 (0.54–1.28) | 0.397 | NA | NA |